ENTITY
Viva Biotech Holdings

Viva Biotech Holdings (1873 HK)

73
Analysis
Health CareChina
Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.
more
Refresh
06 Aug 2020 14:57

Tigermed IPO: Trading Debut

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
403 Views
Share
27 Jul 2020 14:38

Tigermed IPO: Valuation Insights

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
412 Views
Share
20 Jul 2020 01:00

Tigermed IPO: PHIP Highlights the Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
368 Views
Share
26 Apr 2020 20:49

Tigermed IPO Initiation: Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
410 Views
Share
bullishChina Feihe
09 Mar 2020 12:05

Trade Idea Update/HK Connect Weekly: Inclusion Effective Today, XD +10%

In this insight, we will provide an update on the inclusion news today and recap on the basket performance of stocks that are included into the...

Logo
293 Views
Share
x